nivolumab,ipilimumab,cabozantinib
bms,exelixis
['ipilimumab', 'nivo', 'cabozantinib', 'nivolumab', 'renal,(-adrenal)', 'cosmic-313']
 2022 presidential symposium iii: p3 study of cabozantinib in combination with nivolumab and ipilimumab in previously untreated advanced renal cell carcinoma of imdc intermediate or poor risk (cosmic-313) #esmo22 
Pursuing to improve cancer prevention and care. Medical Oncologist @AnkaraUni